Back to Search Start Over

WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19 .

Authors :
Rouadi PW
Idriss SA
Bousquet J
Laidlaw TM
Azar CR
Al-Ahmad MS
Yañez A
Al-Nesf MAY
Nsouli TM
Bahna SL
Abou-Jaoude E
Zaitoun FH
Hadi UM
Hellings PW
Scadding GK
Smith PK
Morais-Almeida M
Maximiliano Gómez R
Gonzalez Diaz SN
Klimek L
Juvelekian GS
Riachy MA
Canonica GW
Peden D
Wong GWK
Sublett J
Bernstein JA
Wang L
Tanno LK
Chikhladze M
Levin M
Chang YS
Martin BL
Caraballo L
Custovic A
Ortego-Martell JA
Lesslar OJL
Jensen-Jarolim E
Ebisawa M
Fiocchi A
Ansotegui IJ
Source :
The World Allergy Organization journal [World Allergy Organ J] 2022 May 14; Vol. 15 (5), pp. 100649. Date of Electronic Publication: 2022 May 14 (Print Publication: 2022).
Publication Year :
2022

Abstract

Background: Chronic cough management necessitates a clear integrated care pathway approach. Primary care physicians initially encounter the majority of chronic cough patients, yet their role in proper management can prove challenging due to limited access to advanced diagnostic testing. A multidisciplinary approach involving otolaryngologists and chest physicians, allergists, and gastroenterologists, among others, is central to the optimal diagnosis and treatment of conditions which underly or worsen cough. These include infectious and inflammatory, upper and lower airway pathologies, or gastro-esophageal reflux. Despite the wide armamentarium of ancillary testing conducted in cough multidisciplinary care, such management can improve cough but seldom resolves it completely. This can be due partly to the limited data on the role of tests (eg, spirometry, exhaled nitric oxide), as well as classical pharmacotherapy conducted in multidisciplinary specialties for chronic cough. Other important factors include presence of multiple concomitant cough trigger mechanisms and the central neuronal complexity of chronic cough. Subsequent management conducted by cough specialists aims at control of cough refractory to prior interventions and includes cough-specific behavioral counseling and pharmacotherapy with neuromodulators, among others. Preliminary data on the role of neuromodulators in a proof-of-concept manner are encouraging but lack strong evidence on efficacy and safety.<br />Objectives: The World Allergy Organization (WAO)/Allergic Rhinitis and its Impact on Asthma (ARIA) Joint Committee on Chronic Cough reviewed the recent literature on management of chronic cough in primary, multidisciplinary, and cough-specialty care. Knowledge gaps in diagnostic testing, classical and neuromodulator pharmacotherapy, in addition to behavioral therapy of chronic cough were also analyzed.<br />Outcomes: This third part of the WAO/ARIA consensus on chronic cough suggests a management algorithm of chronic cough in an integrated care pathway approach. Insights into the inherent limitations of multidisciplinary cough diagnostic testing, efficacy and safety of currently available antitussive pharmacotherapy, or the recently recognized behavioral therapy, can significantly improve the standards of care in patients with chronic cough.<br /> (© 2022 The Author(s).)

Details

Language :
English
ISSN :
1939-4551
Volume :
15
Issue :
5
Database :
MEDLINE
Journal :
The World Allergy Organization journal
Publication Type :
Academic Journal
Accession number :
35600836
Full Text :
https://doi.org/10.1016/j.waojou.2022.100649